表紙
市場調查報告書
商品編碼
1028634

全球阻塞型睡眠呼吸中止症治療設備與睡眠診斷設備市場規模,佔有率,COVID-19的影響分析:2021∼2027年:各設備類型(阻塞型睡眠呼吸中止症治療,睡眠診斷設備)

Sleep Apnea and Diagnostic Devices Market Size, Share & COVID-19 Impact Analysis | Global | 2021-2027 | MedCore | Includes: Sleep Management Devices by Type (Therapeutic Obstructive, Sleep Apnea, and Sleep Diagnostic Devices)

出版日期: | 出版商: iData Research Inc. | 英文 | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

全球阻塞型睡眠呼吸中止症治療設備及睡眠診斷設備的市場規模,預計在預測期間內擴大,2027年各達到49億美元,及4億5,510萬美元。

全球阻塞型睡眠呼吸中止症治療設備市場佔有率,由ResMed、Philips Healthcare、Fisher &Paykel所佔。同樣,全球睡眠診斷設備市場領導者,為Philips Healthcare、Natus、Compumedics。

本報告提供全球阻塞型睡眠呼吸中止症治療設備和睡眠診斷設備市場相關調查,市場概要,以及至2027年的市場預測,市場成長的推動要素與阻礙因素,及加入此市場的主要企業競爭情形等資訊。

目錄

  • 銷售台數,平均銷售價格,市場規模與成長趨勢
  • COVID-19的影響分析
  • 市場促進因素與阻礙因素
  • 至2027年的市場預測,及2017年前的成果資料
  • 最近的企業合併、收購情形
  • 企業簡介和產品系列
  • 主要的其他競爭公司
目錄
Product Code: iDATA_GLARS21_MC_SD

Throughout this medical market research, the publisher analyzed therapeutic obstructive sleep apnea device and sleep diagnostic device companies across more than 70 countries and used their comprehensive methodology to understand the Market Sizes, Unit Sold, Average Selling Prices, Company Market Shares, and to create Accurate Forecasts.

The global therapeutic obstructive sleep apnea device and sleep diagnostic device market sizes are estimated to increase over the forecast period to reach $4.9 billion and $455.1 million, respectively, by 2027.

The majority of the global therapeutic obstructive sleep apnea device market share was controlled by ResMed, Philips Healthcare, and Fisher & Paykel. Similarly, the global sleep diagnostic device market leaders were Philips Healthcare, Natus, and Compumedics.

This global market research spans over 70 countries and includes the global market for obstructive sleep apnea with the positive airway pressure device market and the sleep therapy interface market. In addition, the sleep diagnostic devices market is included with the polysomnography device market and the home respiratory polygraph device market.

MARKET DATA INCLUDED:

  • Unit Sales, Average Selling Prices, Market Size & Growth Trends
  • COVID-19 Impact Analysis
  • Market Drivers & Limiters
  • Market Forecasts Until 2027, and Historical Data to 2017
  • Recent Mergers & Acquisitions
  • Company Profiles and Product Portfolios
  • Leading Competitors

THERAPEUTIC OBSTRUCTIVE SLEEP APNEA DEVICE MARKET INSIGHTS

The primary driver for therapeutic obstructive sleep apnea devices in many markets is the growing awareness among the general population of sleep apnea symptoms and the benefits of its treatment. COVID-19 did not contribute to an increase in sleep-related conditions but, rather, sleep apnea therapy devices are less complex and easier to assemble than ventilators. In cases of severe COVID-19 where patients require acute care, and also in some home care applications, sleep therapy devices can be used in place of ventilators, contributing to a short-term rise in demand.

SLEEP DIAGNPOSTIC DEVICE MARKET INSIGHTS

The total sleep diagnostic device market is expected to grow steadily throughout the forecast period. Dictating a considerable price point are the polysomnography devices, which are by far the most sophisticated and accurate tests in the market. The ease of use and lower price point of home respiratory polygraphy devices will result in the market's notable future growth. In certain cases of COVID-19 where patients require acute care, and also in some home care applications, sleep apnea diagnostic devices can be used in place of ventilators, contributing to a short-term rise in demand.

Therapeutic Obstructive Sleep Apnea and Sleep Diagnostic Device MARKET SHARE INSIGHTS

ResMed, Philips Healthcare, and Fisher & Paykel controlled the global therapeutic obstructive sleep apnea device market share. The global sleep diagnostic device market was led by Philips Healthcare, Natus, and Compumedics.

In 2020, ResMed was the leading competitor in the therapeutic obstructive sleep apnea device market, with a notable presence in both the sleep therapy interface and PAP device segments. Philips Healthcare was the leading competitor in the sleep diagnostic device market, with a notable presence in both the polysomnography device and home respiratory polygraphy device segments.

RESEARCH REGIONAL COVERAGE

Throughout this report, iData Research has covered over 70 countries across the globe in great detail. The regions covered are:

  • North America (the United States and Canada)
  • Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other)
  • Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other)
  • Central and Eastern Europe (Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), and Other)
  • Middle East (Saudi Arabia, UAE, Israel, Iran, Kuwait, Qatar, Bahrain, Oman, and Other)
  • Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other)
  • Africa (South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)